About The Medical Condition Evaluation Studies, FDA Phase III

Find the definition of the medical term Evaluation Studies, FDA Phase III. Evaluation Studies, FDA Phase III defined and explained for easy understanding at the Medical Conditions from ClusterMed.info.
Evaluation Studies, FDA Phase III

Evaluation Studies, FDA Phase III Medical Condition |
---|
What's The Definition Of The Medical Condition Evaluation Studies, FDA Phase III?
Comparative studies to verify the effectiveness of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques determined in phase II studies. During these trials, patients are monitored closely by physicians to identify any adverse reactions from long-term use. These studies are performed on groups of patients large enough to identify clinically significant responses and usually last about three years. This concept includes phase III studies conducted in both the U.S. and in other countries.
|
More Medical Conditions
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Medical Conditions Definitions Of The Day
- Osteolysis, Essential ‐ Syndromes of bone destruction where the cause is not obvious…
- Sleeplessness ‐ Disorders characterized by impairment of the ability to initiate…
- Neuropathies, Tangier Hereditary ‐ A rare autosomal recessive familial disorder of cholesterol metabolism,…
- Polybutyl Cyanoacrylate ‐ A tissue adhesive that is applied as a monomer to moist tissue…
- Self-Referral, Physician ‐ Referral by physicians to testing or treatment facilities in…
- Spikenard ‐ A plant genus in the family ARALIACEAE, order Apiales, subclass…
- Stress Fracture ‐ Fractures due to the strain caused by repetitive exercise. They…
- Eczema, Contact ‐ A type of acute or chronic skin reaction in which sensitivity…
- Dental Pins ‐ Small cylindrical pieces of metal used to enhance…
- Epidermolysis Bullosa Simplex Kobner ‐ Form of epidermolysis bullosa characterized by autosomal dominant…